KGP-25 is an inhibitor of voltage-gated sodium channel 1.8 ( Nav1.8 ), which can be used for analgesia by targeting Nav1.8 in the peripheral nervous system (PNS). KGP-25 can also target γ-aminobutyric acid subtype A receptor ( GABA A ) in the central nervous system (CNS) for general anesthesia.